T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine.
Ohishi
K
K
Laboratory of Molecular Oncology, Tsukuba Life Science Center (RIKEN), Ibaraki, Japan.
Ikawa
Y
Y
D000818:Animals; D000917:Antibody Formation; D002417:Cattle; D002986:Clinical Trials as Topic; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000276:immunology*; D001909:Leukemia Virus, Bovine / Q000254:growth & development / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D012190:Retroviridae / Q000276:immunology; D012756:Sheep; D012867:Skin / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination; D014765:Viral Vaccines / Q000276:immunology*
D011993:Recombinant Fusion Proteins; D014765:Viral Vaccines